Morgan Stanley significantly raised its bull-case price target for Rocket Lab (RKLB) to $293 from $185 on Wednesday, signaling growing confidence in the company's strategic expansion. The upgrade comes amid a volatile period for space stocks, with Rocket Lab shares declining sharply on Tuesday before stabilizing in late trading.
Rocket Lab's Strategic Pivot
Analysts led by Kristine Liwag highlighted that Rocket Lab is evolving beyond a pure-play launch provider into a comprehensive space infrastructure company, drawing comparisons to a smaller-scale SpaceX. According to MarketWatch, Liwag emphasized that substantial value in the space economy comes from space-based infrastructure and recurring services, not just launch capabilities.
Shares of Rocket Lab traded at $83.35 late Wednesday, essentially flat from the prior close, after moving between $80.51 and $87.50 during the regular session. The stock had plunged 9.32% on Tuesday to close at $84.41, with turnover exceeding $638.5 million, making it the biggest loser among space names that day.
Key Catalysts: Iridium Deal and Space Force Wins
Investors are closely watching the company's $8 billion acquisition of satellite-communications provider Iridium, announced last month. The deal provides Rocket Lab with a low-Earth-orbit satellite network, valuable L-band spectrum, and access to over 2.55 million users. This move mirrors SpaceX's integration of Starlink with its launch operations, positioning Rocket Lab to combine launch services, spacecraft manufacturing, and satellite communications under one roof.
Additionally, Rocket Lab announced Tuesday the successful completion of its role in the U.S. Space Force's VICTUS HAZE mission, which included launch, spacecraft activation, and on-orbit proximity operations ahead of schedule. CEO Peter Beck stated the company had "set the new standard" in responsive space capabilities.
Financial Performance and Backlog
Rocket Lab reported first-quarter revenue of $200.3 million, a 63.5% increase year-over-year, with a backlog of $2.2 billion in contracted work. While backlog indicates strong future demand, it does not guarantee profitability. The company's growth trajectory is impressive, but its high valuation leaves little margin for error.
The Neutron Risk
Despite the bullish outlook, significant risks remain. Trefis noted that Rocket Lab's stock experienced a 70% decline from peak to trough during the 2022 inflation and Federal Reserve tightening cycle, far outpacing broader market losses. The company's long-term prospects hinge on the Neutron rocket, a larger launch vehicle currently under development that is critical for handling bigger payloads and satellite constellations.
Any delays, test failures, funding constraints from the Iridium acquisition, or waning investor appetite for high-growth, unprofitable names could trigger a sharp reversal. The stock currently trades at a premium that leaves little room for execution missteps.
Investors will be watching for new contracts, upcoming launches, and progress on Iridium integration to determine whether Rocket Lab can translate its growth story into sustainable cash flow before market volatility intensifies.
